Maxim Noeraparast

7PUBLICATIONS
17CO-AUTHORS
Cancer geneticsPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Cancer cell biologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 08, 2026
Variant-Specific Landscape of Mutual Exclusivity Among BRAF, EGFR, and KRAS Oncogenes Reveals Overlap With Functionally Antagonistic Mutant Pairs.

|Mar 10, 2026
Multi-omic profiling defines three distinct molecular subtypes of urothelial carcinoma with implications for precision therapy.

Nils C H van Creij, Piotr Tymoszuk, Florian Handle

|Jan 11, 2026
Clinical Significance and Therapeutic Potential of Long Non-Coding RNA H19 in Soft Tissue Sarcoma.

Stephan Jahn, Katarina Krajina, Maria Anna Smolle

|Jan 08, 2025
Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutations.

Julianne S Funk, Maria Klimovich, Daniel Drangenstein

|Aug 20, 2024
FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapies.

Maxim Noeraparast, Katarina Krajina, Renate Pichler

|Mar 15, 2024
ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery framework.

Oleg Timofeev, Philippe Giron, Steffen Lawo

Pageof 2

Frequent Collaborators

1 joint publications

Rajendra Bahadur Shahi

1 joint publications

Steffen Lawo

1 joint publications

Julianne S Funk

1 joint publications

Pascal Hunold